Hutchmed Drc Stock Performance
| HCM Stock | USD 16.45 0.23 1.38% |
On a scale of 0 to 100, HUTCHMED DRC holds a performance score of 5. The company retains a Market Volatility (i.e., Beta) of 2.31, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, HUTCHMED DRC will likely underperform. Please check HUTCHMED DRC's expected short fall, and the relationship between the value at risk and daily balance of power , to make a quick decision on whether HUTCHMED DRC's current trending patterns will revert.
Risk-Adjusted Performance
5 of 100
Weak | Strong |
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in HUTCHMED DRC are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very weak fundamental indicators, HUTCHMED DRC displayed solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (1.38) | Five Day Return (8.00) | Year To Date Return (6.05) | Ten Year Return 21.85 | All Time Return 21.85 |
Last Split Factor 1:1 | Last Split Date 2019-05-30 |
1 | HUTCHMED Highlights Presentation of Phase III Data on Fruquintinib in Second-Line Gastric Cancer at ASCO Plenary Series Session | 02/07/2024 |
2 | Business Expansion, Acquisitions Aid ADP Amid Competition | 03/01/2024 |
3 | PDS Announces Rick Austin as New Vice President of Engineering | 03/07/2024 |
4 | ISG Provider Lens HCM Technology 2024 Declares HiBob a Rising Star in HCM for Small and Mid-Markets | 03/13/2024 |
5 | Nucleus Research Releases 2024 SMB Human Capital Management Technology Value Matrix | 03/19/2024 |
6 | HUTCHMED Initiates Registration Stage of the ESLIM-02 Phase IIIII Trial of Sovleplenib for Warm Antibody Autoimmune Hemolytic Anemia in China | 03/22/2024 |
7 | HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sintilimab for the Treatment of Advanced EndometrialCancer with... | 04/02/2024 |
8 | Cytokinetics Presents Additional 48-Week Data From FOREST-HCM, the Open Label Extension Clinical Study of Aficamten, at The American College of Cardiology 73 An... | 04/05/2024 |
9 | Cytokinetics Announces Three Late Breaking Clinical Trial Presentations Relating to SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congres... | 04/10/2024 |
10 | PDS Announces 50th Anniversary | 04/15/2024 |
11 | Customer Praise Earns UKG Three New Honors for Delivering Great Experiences | 04/17/2024 |
| Begin Period Cash Flow | 313.3 M |
HUTCHMED |
HUTCHMED DRC Relative Risk vs. Return Landscape
If you would invest 1,427 in HUTCHMED DRC on January 19, 2024 and sell it today you would earn a total of 218.00 from holding HUTCHMED DRC or generate 15.28% return on investment over 90 days. HUTCHMED DRC is generating 0.315% of daily returns assuming volatility of 4.293% on return distribution over 90 days investment horizon. In other words, 37% of stocks are less volatile than HUTCHMED, and above 94% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
HUTCHMED DRC Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for HUTCHMED DRC's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as HUTCHMED DRC, and traders can use it to determine the average amount a HUTCHMED DRC's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0734
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | HCM | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.29 actual daily | 37 63% of assets are more volatile |
Expected Return
| 0.32 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
| 0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average HUTCHMED DRC is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of HUTCHMED DRC by adding it to a well-diversified portfolio.
HUTCHMED DRC Fundamentals Growth
HUTCHMED Stock prices reflect investors' perceptions of the future prospects and financial health of HUTCHMED DRC, and HUTCHMED DRC fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on HUTCHMED Stock performance.
| Return On Equity | 0.15 | ||||
| Return On Asset | 0.01 | ||||
| Profit Margin | 0.12 % | ||||
| Operating Margin | (0.31) % | ||||
| Current Valuation | 27.69 B | ||||
| Shares Outstanding | 170.73 M | ||||
| Price To Earning | 335.94 X | ||||
| Price To Book | 4.18 X | ||||
| Price To Sales | 3.74 X | ||||
| Revenue | 838 M | ||||
| Gross Profit | (271.59 M) | ||||
| EBITDA | 25.53 M | ||||
| Net Income | 100.78 M | ||||
| Cash And Equivalents | 829.71 M | ||||
| Cash Per Share | 4.91 X | ||||
| Total Debt | 86.13 M | ||||
| Current Ratio | 3.18 X | ||||
| Book Value Per Share | 0.86 X | ||||
| Cash Flow From Operations | 219.26 M | ||||
| Earnings Per Share | 0.60 X | ||||
| Market Capitalization | 3.06 B | ||||
| Total Asset | 1.28 B | ||||
| Retained Earnings | (870.87 M) | ||||
| Working Capital | 693.81 M | ||||
| Current Asset | 187.47 M | ||||
| Current Liabilities | 96.7 M | ||||
About HUTCHMED DRC Performance
To evaluate HUTCHMED DRC Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when HUTCHMED DRC generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare HUTCHMED Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand HUTCHMED DRC market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents HUTCHMED's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 47.72 | 94.99 | |
| Return On Tangible Assets | 0.08 | 0.08 | |
| Return On Capital Employed | 0.02 | 0.02 | |
| Return On Assets | 0.08 | 0.08 | |
| Return On Equity | 0.14 | 0.14 |
Things to note about HUTCHMED DRC performance evaluation
Checking the ongoing alerts about HUTCHMED DRC for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for HUTCHMED DRC help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| HUTCHMED DRC had very high historical volatility over the last 90 days | |
| Latest headline from finance.yahoo.com: Customer Praise Earns UKG Three New Honors for Delivering Great Experiences |
- Analyzing HUTCHMED DRC's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether HUTCHMED DRC's stock is overvalued or undervalued compared to its peers.
- Examining HUTCHMED DRC's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating HUTCHMED DRC's management team can have a significant impact on its success or failure. Reviewing the track record and experience of HUTCHMED DRC's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of HUTCHMED DRC's stock. These opinions can provide insight into HUTCHMED DRC's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in HUTCHMED DRC. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in HUTCHMED Stock, please use our How to Invest in HUTCHMED DRC guide.Note that the HUTCHMED DRC information on this page should be used as a complementary analysis to other HUTCHMED DRC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Complementary Tools for HUTCHMED Stock analysis
When running HUTCHMED DRC's price analysis, check to measure HUTCHMED DRC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HUTCHMED DRC is operating at the current time. Most of HUTCHMED DRC's value examination focuses on studying past and present price action to predict the probability of HUTCHMED DRC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HUTCHMED DRC's price. Additionally, you may evaluate how the addition of HUTCHMED DRC to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |
Is HUTCHMED DRC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of HUTCHMED DRC. If investors know HUTCHMED will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about HUTCHMED DRC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.6 | Revenue Per Share 4.93 | Quarterly Revenue Growth 0.36 | Return On Assets 0.01 | Return On Equity 0.1465 |
The market value of HUTCHMED DRC is measured differently than its book value, which is the value of HUTCHMED that is recorded on the company's balance sheet. Investors also form their own opinion of HUTCHMED DRC's value that differs from its market value or its book value, called intrinsic value, which is HUTCHMED DRC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because HUTCHMED DRC's market value can be influenced by many factors that don't directly affect HUTCHMED DRC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between HUTCHMED DRC's value and its price as these two are different measures arrived at by different means. Investors typically determine if HUTCHMED DRC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, HUTCHMED DRC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.